RT @FrontImmunol: New Research: Incidence and Risk of Infection Associated With Fingolimod in Patients With Multiple Sclerosis: A Systemati…
101 followers
7,381 followers
RT @FrontImmunol: New Research: Incidence and Risk of Infection Associated With Fingolimod in Patients With Multiple Sclerosis: A Systemati…
32,635 followers
New Research: Incidence and Risk of Infection Associated With Fingolimod in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis of 8,448 Patients From 12 Randomized Controlled Trials: Background and Aims: There is a… https://t.co/ECY9KL
16,356 followers
They say Gilenya (fingolimod) spares the effector t-cells, but this analysis of 8448 people with MS from 12 randomized trials suggests it does increase the risk of infection, though only modestly (by 16%) https://t.co/Yl40CWtv7t https://t.co/fGrtUrTr9b